American Journal of Cardiology
Volume 104, Issue 10 , Pages 1393-1397 , 15 November 2009

Usefulness of Triglycerides-to–High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men

  • Alberto Cordero, PhD

      Affiliations

    • Department of Cardiology, Hospital Universitario de San Juan, Alicante, Spain
    • Corresponding Author InformationCorresponding author: Tel: 0034-9659-38730; fax: 0034-9659-38652
    • ,
  • Eva Andrés, PhD

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • Beatriz Ordoñez, PhD

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • Montserrat León, PhD

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • Martín Laclaustra, PhD

      Affiliations

    • Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
    • ,
  • Alberto Grima, PhD

      Affiliations

    • Department of Preventive Cardiology, Asepeyo, Valencia, Spain
    • ,
  • Emilio Luengo, PhD

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • José Moreno, MD

      Affiliations

    • Department of Cardiology, Hospital Universitario de San Juan, Alicante, Spain
    • ,
  • María Bes

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • Isaac Pascual, MD

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • Fernando Civeira, PhD

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • Miguel Pocoví, PhD

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • Eduardo Alegría, PhD

      Affiliations

    • Department of Cardiology, Policlínica Gipuzkoa, San Sebastian, Spain
    • ,
  • José A. Casasnovas, PhD

      Affiliations

    • Cardiovascular Research Unit, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
    • ,
  • MESYAS (MEtabolic Syndrome Active Subjects) Study Investigators

Received 14 April 2009 ,Revised 2 July 2009 ,Accepted 2 July 2009.

References 

  1. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes. 2004;53:1782–1789
  2. de Simone G, Devereux RB, Chinali M, Roman MJ, Best LG, Welty TK, et al. Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study. Hypertension. 2006;47:162–167
  3. Kumanyika SK, Obarzanek E, Stettler N, Bell R, Field AE, Fortmann SP, et al. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association council on epidemiology and prevention, interdisciplinary committee for prevention (formerly the expert panel on population and prevention science). Circulation. 2008;118:428–464
  4. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105–2120
  5. Cordero A, Laclaustra M, Leon M, Casasnovas JA, Grima A, Luengo E, et al. Comparison of serum lipid values in subjects with and without the metabolic syndrome. Am J Cardiol. 2008;102:424–428
  6. Cordero A, Leon M, Andres E, Ordonez B, Laclaustra M, Grima A, et al. Gender differences in obesity related cardiovascular risk factors in Spain. Prev Med. 2009;48:134–139
  7. Diercks DB, Roe MT, Mulgund J, Pollack CV, Kirk JD, Gibler WB, et al. The obesity paradox in non–ST-segment elevation acute coronary syndromes: results from the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the American College of Cardiology/American Heart Association guidelines quality improvement initiative. Am Heart J. 2006;152:140–148
  8. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–678
  9. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863–870
  10. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640–1649
  11. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol. 2008;52:605–615
  12. Zeller M, Steg PG, Ravisy J, Lorgis L, Laurent Y, Sicard P, et al. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation. 2008;118:482–490
  13. Schulte H, Cullen P, Assmann G. Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM). Atherosclerosis. 1999;144:199–209
  14. Alegria E, Cordero A, Laclaustra M, Grima A, Leon M, Casasnovas JA, et al. Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry. Rev Esp Cardiol. 2005;58:797–806
  15. Cordero A, Laclaustra M, Leon M, Grima A, Casasnovas JA, Luengo E, et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment (A Metabolic Syndrome in Active Subjects in Spain (MESYAS) registry substudy). Am J Hypertens. 2006;19:189–196
  16. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
  17. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation. 2000;102:179–184
  18. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  19. Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003–2004. Am Heart J. 2008;156:112–119
  20. Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis. 2000;153:263–272
  21. deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J Am Coll Cardiol. 2008;51:49–55
  22. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520–2525
  23. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802–809
  24. Rutter MK, Wilson PW, Sullivan LM, Fox CS, D'Agostino RB, Meigs JB. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation. 2008;117:1003–1009
  25. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403–414
  26. Hanak V, Munoz J, Teague J, Stanley A, Bittner V. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol. 2004;94:219–222
  27. Koba S, Hirano T, Ito Y, Tsunoda F, Yokota Y, Ban Y, et al. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis. 2006;189:206–214
  28. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357:1301–1310
  29. Madala MC, Franklin BA, Chen AY, Berman AD, Roe MT, Peterson ED, et al. Obesity and age of first non–ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008;52:979–985

PII: S0002-9149(09)01338-1

doi: 10.1016/j.amjcard.2009.07.008

American Journal of Cardiology
Volume 104, Issue 10 , Pages 1393-1397 , 15 November 2009

Article Tools

* Image Usage & Resolution